PATENT CLAIM ANALYSIS

Application Number: 15773048
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "019300"]

Abstract:
The use of the C-terminal region of one or more phytocystatin(s) for the curative or prophylactic treatment of tumors and/or inhibition of metastases in mammals or other vertebrates. In one embodiment, the pharmaceutical composition of the invention comprises a pharmaceutically acceptable carrier and a polypeptide containing only the C-terminal region of one or more phytocystatin(s). In another embodiment, the composition of the invention comprises a gene construct for the in vivo expression of said polypeptide.

Claim (Index 6):
The composition according to  claim 3 , wherein it is in the oral, sublingual, injectable, transdermal, topical, inhalable or suppository dosage form.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.82979
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09610313', '11709868', '12774158', '14889656', '15549803']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7702012142574739
- 35 USC 102 Novelty (BERT): 0.4961032315610021
- Combined Prediction Score: 0.7427914159878268
- Mean Citation Score: 210.04635
- Max Citation Score: 213.10278
- Similarity Product: 144.38053959566116

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test